Goldman Sachs
AFIB

Goldman Sachs’s Acutus Medical Inc AFIB Stock Holding History

Goldman Sachs’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,391
Closed -$2.3K – 5971
2023
Q4 		$2.3K Buy
+11,391
New +$4.46K ﹤0.01% 5554
2022
Q3 		– Sell
-45,773
Closed -$51K – 6640
2022
Q2 		$51K Sell
45,773
-18,304
-29% -$15.7K ﹤0.01% 6023
2022
Q1 		$89K Sell
64,077
-1,327,829
-95% -$2.84M ﹤0.01% 6142
2021
Q4 		$4.75M Buy
1,391,906
+1,380,072
+11,662% +$7.77M ﹤0.01% 3463
2021
Q3 		$105K Buy
+11,834
New +$156K ﹤0.01% 5898
2021
Q2 		– Sell
-64,776
Closed -$866K – 6598
2021
Q1 		$866K Buy
+64,776
New +$1.46M ﹤0.01% 4721
2020
Q4 		– Sell
-15,594
Closed -$465K – 5770
2020
Q3 		$465K Buy
+15,594
New +$473K ﹤0.01% 4514

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs's AFIB Position: Q1 2024 in Review

Goldman Sachs sold out of Acutus Medical Inc (AFIB) in Q1 2024, closing a stake of 11,391 shares — an estimated $2.3K sold.

Goldman Sachs first reported a position in AFIB in Q3 2020 and held it in 7 quarters. The position peaked at $4.75M in Q4 2021. 23 funds tracked by Wall St. Rank hold AFIB as of Q1 2024.

  • Goldman Sachs reported no remaining Acutus Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Goldman Sachs sold 11,391 Acutus Medical Inc shares in Q1 2024, an estimated $2.3K.
  • Goldman Sachs first reported a position in Acutus Medical Inc in Q3 2020 and held it in 7 quarters.
  • Goldman Sachs's Acutus Medical Inc position peaked at $4.75M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2024.

Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.